Skip to content
Research Article Open access CC BY 4.0

Commensals and Foodborne Pathogens can Arbitrate Epithelial-carcinogenesis

Yvon Woappi, Om V. Singh

Microbiology Research Journal International · pp. 1–11 · Published 10 Jun 2016

10.9734/BMRJ/2016/26690

Abstract

Major shifts in intestinal commensal bacteria often result in changes in CD4+ T lymphocyte populations, leading to an influx of Th17 cells, chronic inflammation, and eventually cancer. Consequently, the inappropriate propagation of certain commensal species in the gut has been associated with mucosal inflammatory diseases and cancer development. Recent experiments investigating the relationships between food-borne pathogens, enteric bacteria, and cancer have exposed the ability of certain bacterial species to significantly reduce tumor size and tumor progression in mice. In similar studies, pro-inflammatory Th17 and Th1 cells were at times found present along with anti-inflammatory Treg populations in the intestinal mucosa. This antitumor response was mediated by a balanced production of pro- and anti-inflammatory cytokines, resulting in a controlled threshold of mucosal immunity largely moderated by CD4+ T lymphocyte populations, through a dendritic cell-dependent pathway. These findings provide new evidence that certain species of bacteria can help manage subcutaneous tumor development by calibrating mucosal and, in some instances, systemic thresholds of innate and adaptive immunity.

Foodborne pathogens carcinogenesis inflammatory disease commensal bacteria toxins immunity

References (57)

  1. 1 Inflammation and cancer [DOI]
  2. 2 Foodborne Illness Acquired in the United States—Major Pathogens [DOI]
  3. 3 Role of the Microbiota in Immunity and Inflammation [DOI]
  4. 4 The gut microbiota shapes intestinal immune responses during health and disease [DOI]
  5. 5 UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS [DOI]
  6. 6 The Treatment-Naive Microbiome in New-Onset Crohn’s Disease [DOI]
  7. 7 An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System [DOI]
  8. 8 The gut microbiota, bacterial metabolites and colorectal cancer [DOI]
  9. 9 Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis [DOI]
  10. 10 Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment [DOI]
  11. 11 IL-10: The Master Regulator of Immunity to Infection [DOI]
  12. 12 The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide [DOI]
  13. 13 Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. [DOI]
  14. 14 Immune adaptations that maintain homeostasis with the intestinal microbiota [DOI]
  15. 15 Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability [DOI]
  16. 16 Coadaptation of Helicobacter pylori and humans: ancient history, modern implications [DOI]
  17. 17 Microbiota disbiosis is associated with colorectal cancer [DOI]
  18. 18 Microbial Dysbiosis Is Associated with Human Breast Cancer [DOI]
  19. 19 IL-17 cytokines in immunity and inflammation [DOI]
  20. 20 Priming of Natural Killer Cells by Nonmucosal Mononuclear Phagocytes Requires Instructive Signals from Commensal Microbiota [DOI]
  21. 21 Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production [DOI]
  22. 22 Compartmentalized and systemic control of tissue immunity by commensals [DOI]
  23. 23 Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice [DOI]
  24. 24 The love–hate relationship between bacterial polysaccharides and the host immune system [DOI]
  25. 25 The Human Neonatal Gut Microbiome: A Brief Review [DOI]
  26. 26 Commensal-Associated Molecular Patterns Induce Selective Toll-Like Receptor-Trafficking from Apical Membrane to Cytoplasmic Compartments in Polarized Intestinal Epithelium [DOI]
  27. 27 A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2 [DOI]
  28. 28 Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma [DOI]
  29. 29 Th17 Cytokines and the Gut Mucosal Barrier [DOI]
  30. 30 Overexpression of interleukin‐23, but not interleukin‐17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis [DOI]
  31. 31 The Occurrence and Prevention of Foodborne Disease in Vulnerable People [DOI]
  32. 32 CD4+CD25+ Regulatory Lymphocytes Induce Regression of Intestinal Tumors in ApcMin/+ Mice [DOI]
  33. 33 Mining the Human Gut Microbiota for Effector Strains that Shape the Immune System [DOI]
  34. 34 The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut [DOI]
  35. 35 Helicobacter pylori Infection and Risk of Cardia Cancer and Non-Cardia Gastric Cancer: A Nested Case-Control Study [DOI]
  36. 36 T Cells Activated by Zwitterionic Molecules Prevent Abscesses Induced by Pathogenic Bacteria [DOI]
  37. 37 Endotoxin and Cancer [DOI]
  38. 38 CD4 + T Cells, Including Th17 and Cycling Subsets, Are Intact in the Gut Mucosa of HIV-1-Infected Long-Term Nonprogressors [DOI]
  39. 39 IL-27 Regulates Homeostasis of the Intestinal CD4+ Effector T Cell Pool and Limits Intestinal Inflammation in a Murine Model of Colitis [DOI]
  40. 40 Anticancer drugs need bugs [DOI]
  41. 41 IL-10 and Macrophages Orchestrate Gut Homeostasis [DOI]
  42. 42 Immune Disorders and Its Correlation with Gut Microbiome [DOI]
  43. 43 Bacterial Quorum Sensing Molecule N-3-Oxo-Dodecanoyl-L-Homoserine Lactone Causes Direct Cytotoxicity and Reduced Cell Motility in Human Pancreatic Carcinoma Cells [DOI]
  44. 44 Decreased mucosal interleukin-4 (IL-4) production in gut inflammation. [DOI]
  45. 45 Effect of Lactobacillus plantarum LP‐Onlly on gut flora and colitis in interleukin‐10 knockout mice [DOI]
  46. 46 IL-21 comes of age as a regulator of effector T cells in the gut [DOI]
  47. 47 Microbial Learning Lessons: SFB Educate the Immune System [DOI]
  48. 48 Bacteria Moving into Focus of Human Cancer [DOI]
  49. 49 Uhrf to Treg cells: reinforcing the mucosal peacekeepers [DOI]
  50. 50 Proliferation of Immature T Cells within the Splenocytes of Athymic Mice by Pseudomonas Exotoxin A [DOI]
  51. 51 An ecological and evolutionary perspective on human–microbe mutualism and disease [DOI]
  52. 52 Gut microbiota imbalance and colorectal cancer [DOI]
  53. 53 Identifying Gut Microbe–Host Phenotype Relationships Using Combinatorial Communities in Gnotobiotic Mice [DOI]
  54. 54 Interleukin 13 and its role in gut defence and inflammation [DOI]
  55. 55 Analysis of the antitumoral mechanisms of lipopolysaccharide against glioblastoma multiforme [DOI]
  56. 56 Biological Activities of Uric Acid in Infection Due to Enteropathogenic and Shiga-Toxigenic Escherichia coli [DOI]
  57. 57 Will sewage workers with endotoxin related symptoms have the benefit of reduced lung cancer? [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

101

Page views

0

PDF downloads

17

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.